Financial Information

Shareholder Tools
Search Investor Relations

In June 2013, Mirati Therapeutics, Inc. became the ultimate parent corporation of MethylGene Inc. and subsidiaries by a court and shareholder-approved plan of arrangement.

Here you will find a summary of Mirati Therapeutics Inc.'s latest financial information.

Latest Earnings Release and 10-Q

  Date Filed Format Size
Second Quarter Financial Results HTML file N/A
Second Quarter Form 10-Q Aug 8, 2014 HTML file  PDF file   View XBRL 455.8 KB   Add to Briefcase
First Quarter Form 10-Q May 15, 2014 HTML file  PDF file   View XBRL 444.0 KB   Add to Briefcase
 

Latest Annual Report and 10-K

  Date Filed Format Size
2013 Annual Report   PDF 850.1 KB   Add to Briefcase
Form 10-K Mar 17, 2014 HTML file  PDF file   View XBRL 822.2 KB   Add to Briefcase
 

Latest Proxy Statement

  Date Filed Format Size
Proxy Statement Apr 17, 2014 HTML file  PDF file 626.4 KB   Add to Briefcase
Add to Briefcase = add PDF file to Briefcase
Subscribe to News

Please fill out the form below to be added to Mirati's press release distribution list.

Your Name (required)

Your Company

Your Email (required)

captcha

×